Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-04

Clinical Trial Update: Fenofibrate Versus Curcumin in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fenofibrate to curcumin in adults with type 2 diabetes mellitus; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Rehab Werida | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED